Sale!

SLC26A5 Gene Deafness Autosomal Recessive Type 61 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC26A5 gene, also known as the prestin gene, is crucial for normal hearing function. Mutations in this gene can lead to Deafness Autosomal Recessive Type 61 (DFNB61), a form of hereditary hearing loss. This condition is characterized by the absence or severe reduction of hearing from birth. It is passed down through families in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

To diagnose this specific type of genetic hearing loss, a genetic test targeting the SLC26A5 gene can be conducted. This test involves analyzing the DNA to identify mutations in the SLC26A5 gene that are known to cause DFNB61. It is a crucial step for families with a history of hearing loss, as it can confirm the diagnosis, provide information about the inheritance pattern, and inform decisions about family planning.

In the United Arab Emirates, this specific genetic test is available at DNA Labs UAE. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced technology and staffed by professionals skilled in genetic testing and counseling. The test is performed with a simple blood sample or cheek swab from the individual. Results from the test can help in the early detection of hearing loss, enabling timely intervention and management strategies to improve the quality of life for those affected by DFNB61.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC26A5 Gene Deafness Autosomal Recessive Type 61 Genetic Test

Cost: AED 4400.0

Overview

The SLC26A5 gene is associated with a type of deafness known as autosomal recessive type 61. This genetic test aims to identify any mutations or variations in the SLC26A5 gene that may be causing or contributing to an individual’s deafness.

Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the SLC26A5 gene deafness genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A12.

Test Details

The SLC26A5 gene is responsible for autosomal recessive type 61 deafness. This means that both copies of the gene, one from each parent, must have the gene mutation for the individual to be affected by the condition. NGS (Next-Generation Sequencing) genetic testing is utilized to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of SLC26A5 gene deafness, NGS genetic testing involves sequencing the SLC26A5 gene to detect any mutations or variations that may be contributing to the individual’s deafness. The identification of the specific genetic mutation or variation can aid in confirming a diagnosis of SLC26A5 gene deafness and provide valuable information for genetic counseling and potential treatment options.

Test Name SLC26A5 Gene Deafness autosomal recessive type 61 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A12
Test Details

The SLC26A5 gene is associated with a type of deafness known as autosomal recessive type 61. This means that the gene mutation needs to be present in both copies of the gene (one from each parent) for the individual to be affected by the condition.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of SLC26A5 gene deafness, an NGS genetic test would involve sequencing the SLC26A5 gene to look for any mutations or variations that may be causing or contributing to the individual’s deafness.

By identifying the specific genetic mutation or variation, NGS genetic testing can help in confirming a diagnosis of SLC26A5 gene deafness and provide valuable information for genetic counseling and potential treatment options.